Product Information
ONYDA XR 0.1 MG/ML SUSPENSION is a brand product labeled by NextWave Pharmaceuticals, Inc, priced at $13.3781 per ML under NDC 24478014803. Its NADAC has been published 75 times since Jan 22, 2025.
The High Outlier badge above means this manufacturer's average price in the Clonidine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.1 mg/mL
Manufacturer
NextWave Pharmaceuticals, IncNDC
24478014803
Classification
Brand
Dosage Form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONIDINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA217645On Market Since
8/13/2024
Pharmacological Classes
Price Statistics
The NADAC for ONYDA XR 0.1 MG/ML SUSPENSION has been published 75 times since Jan 22, 2025, and over the history we have for it it has declined 12.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.3781 per ML |
|---|---|
| All-time high | $15.3592 (Mar 5, 2025) |
| All-time low | $12.8369 (Nov 19, 2025) |
| 52-week high | $13.3992 |
| 52-week low | $12.8369 |
| Median price | $12.8953 |
| Average price | $13.2973 |
| Largest weekly change | -16.0% (Mar 12, 2025) |
| Weeks tracked | 75 |
| Tracking since | Jan 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Clonidine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ONYDA XR 0.1 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for ONYDA XR 0.1 MG/ML SUSPENSION, manufactured by NextWave Pharmaceuticals, Inc, is $13.3781 per ML (NDC 24478014803), effective Jun 24, 2026.
How has the price of ONYDA XR 0.1 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for ONYDA XR 0.1 MG/ML SUSPENSION has declined 12.9%. It has been tracked across 75 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for ONYDA XR 0.1 MG/ML SUSPENSION?
Since Jan 22, 2025, the NADAC for ONYDA XR 0.1 MG/ML SUSPENSION has ranged from a low of $12.8369 (Nov 19, 2025) to a high of $15.3592 (Mar 5, 2025), with a median of $12.8953 per ML.
Are there cheaper alternatives to ONYDA XR 0.1 MG/ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ONYDA XR 0.1 MG/ML SUSPENSION, so no direct lower-cost alternative is listed.
Who manufactures ONYDA XR 0.1 MG/ML SUSPENSION?
ONYDA XR 0.1 MG/ML SUSPENSION (NDC 24478014803) is labeled by NextWave Pharmaceuticals, Inc, and CMS classifies it as a brand product.
Related Drugs
Same classification